Pub. Date : 2003
PMID : 14687441
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | A number of open-label studies, where patients were switched from donepezil to rivastigmine, have indicated that approximately 50% of patients experiencing a lack/loss of efficacy with donepezil (a selective acetylcholinesterase [AChE] inhibitor) respond to subsequent treatment with rivastigmine (a dual AChE and butyrylcholinesterase inhibitor). | Rivastigmine | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
2 | A number of open-label studies, where patients were switched from donepezil to rivastigmine, have indicated that approximately 50% of patients experiencing a lack/loss of efficacy with donepezil (a selective acetylcholinesterase [AChE] inhibitor) respond to subsequent treatment with rivastigmine (a dual AChE and butyrylcholinesterase inhibitor). | Rivastigmine | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
3 | A number of open-label studies, where patients were switched from donepezil to rivastigmine, have indicated that approximately 50% of patients experiencing a lack/loss of efficacy with donepezil (a selective acetylcholinesterase [AChE] inhibitor) respond to subsequent treatment with rivastigmine (a dual AChE and butyrylcholinesterase inhibitor). | Rivastigmine | acetylcholinesterase (Cartwright blood group) | Homo sapiens |